These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 30235493)
1. Altered TEG Parameters Identify Hypercoagulablilty and are of Diagnosis Value for Papillary Thyroid Carcinoma Patients. Lu S; Kang R; Wang Y; Zhu M; Zhao L; Xu Q; Song Y; Liu C Exp Clin Endocrinol Diabetes; 2020 May; 128(5):297-302. PubMed ID: 30235493 [TBL] [Abstract][Full Text] [Related]
2. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter. Hou X; Jiang L; Chen C; Zhu X; Ge M Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer. Klimaite R; Kazokaite M; Kondrotiene A; Dauksiene D; Verkauskiene R; Zilaitiene B; Dauksa A Anticancer Res; 2022 May; 42(5):2289-2299. PubMed ID: 35489725 [TBL] [Abstract][Full Text] [Related]
4. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma. Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746 [TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma]. Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201 [No Abstract] [Full Text] [Related]
6. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter. Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738 [TBL] [Abstract][Full Text] [Related]
7. Low level of plasma fibulin-1 in patients with thyroid lesions: a case-control study and literature review. Hedayati M; Abooshahab R; Razavi SA; Salehipour P; Ahmadikia K; Boroomand S Mol Biol Rep; 2020 Nov; 47(11):8859-8866. PubMed ID: 33106982 [TBL] [Abstract][Full Text] [Related]
8. Katanin subunits p60 and p80, potential biomarkers for papillary thyroid carcinoma to distinguish nodular goiter: STROBE. Wu Z; Guo M; Yang J; Xiao Y; Liu W Medicine (Baltimore); 2022 Jun; 101(24):e29402. PubMed ID: 35713446 [TBL] [Abstract][Full Text] [Related]
9. Mean platelet volume could be a possible biomarker for papillary thyroid carcinomas. Baldane S; Ipekci SH; Sozen M; Kebapcilar L Asian Pac J Cancer Prev; 2015; 16(7):2671-4. PubMed ID: 25854344 [TBL] [Abstract][Full Text] [Related]
10. Higher urinary bisphenol A concentration and excessive iodine intake are associated with nodular goiter and papillary thyroid carcinoma. Zhou Z; Zhang J; Jiang F; Xie Y; Zhang X; Jiang L Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28684549 [TBL] [Abstract][Full Text] [Related]
11. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers? Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140 [TBL] [Abstract][Full Text] [Related]
12. Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma. Wang Y; Zhou S; Wang D; Wei T; Zhu J; Li Z Front Endocrinol (Lausanne); 2021; 12():737638. PubMed ID: 34803909 [TBL] [Abstract][Full Text] [Related]
13. A comparison of haemogram parameters of patients with thyroid papillary cancer and nodular goiter in Van, Turkey. Yildiz S; Eker E; Ozturk M; Alay M J Pak Med Assoc; 2019 Nov; 69(11):1642-1646. PubMed ID: 31740871 [TBL] [Abstract][Full Text] [Related]
14. Thromboelastography Parameters Change Significantly in Patients with Endometrial Cancer and Uterine Fibroids. Lu S; Gao W; Li M; Xu Q; Rong J; Song Y; Liu C Clin Lab; 2023 Mar; 69(3):. PubMed ID: 36912292 [TBL] [Abstract][Full Text] [Related]
15. Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. Yao Z; Yin P; Su D; Peng Z; Zhou L; Ma L; Guo W; Ma L; Xu G; Shi J; Jiao B Mol Biosyst; 2011 Sep; 7(9):2608-14. PubMed ID: 21713270 [TBL] [Abstract][Full Text] [Related]
16. [ Zhang X; Su X; Chen WC; Li Y; Yang ZY; Deng WZ; Deng TC; Yang AK Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):435-439. PubMed ID: 28635216 [No Abstract] [Full Text] [Related]
17. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions. Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088 [TBL] [Abstract][Full Text] [Related]
18. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma. Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915 [TBL] [Abstract][Full Text] [Related]
19. TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma. Bychkov A; Sampatanukul P; Shuangshoti S; Keelawat S Pathology; 2016 Aug; 48(5):425-33. PubMed ID: 27311870 [TBL] [Abstract][Full Text] [Related]
20. [Application value of thromboelastography in patients with multiple trauma in emergency department]. Qu Q; Wei X; Hou J; Yang R Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):623-628. PubMed ID: 31198152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]